Navigation Links
Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical
Date:12/20/2013

a duration of 12 weeks, a treatment period that has historically been important to identify clinically meaningful changes as compared to placebo." The Full Research Report on Lexicon Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/b63e_LXRX

--

Wright Medical Group, Inc. Research Report

On December 16, 2013, Wright Medical Group, Inc. (Wright Medical) reported that MicroPort Scientific Corporation (MicroPort) advised the Company that the Hong Kong Stock Exchange has granted clearance of the disclosure circular required with respect to its shareholder meeting to approve the acquisition of the Wright's OrthoRecon business. The Company added that MicroPort has scheduled a shareholder meeting to approve the transaction on January 3, 2014. Wright Medical stated that it expects the transaction to be closed on or about January 9, 2014. Wright Medical added that after closing of the transaction, it plans to provide further details of the financial impacts of the transaction, as well as 2014 financial guidance in its Q4 2013 conference call, scheduled for February 24, 2014. The Full Research Report on Wright Medical Group, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/1782_WMGI

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to m
    '/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol
2. According to Surveyed U.S. Oncologists, Perjeta is Prescribed to Over One-Third of First-Line Advanced/Metastatic HER2-Positive, HR-Negative Breast Cancer Patients
3. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
4. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
5. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
6. Annual General Meeting Schedules, New Drug Applications, Positive Study Results, Conference Participations, and Secondary Offerings - Research Report on Mindray, AcelRx, Merrimack, ZELTIQ, and Clovis
7. Dividends, Recognitions, Positive Opinions, Share Repurchase Programs, and Award Programs - Research Report on BD, Sanofi, GSK, Agilent Technologies, and Align Technology
8. According to Surveyed EU5 Oncologists, Zelboraf Captures 50 Percent Patient Share of the First-Line BRAF-Mutation Positive Malignant Melanoma Population
9. Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy
10. Positive Opinion, Stock Price Movement, and Executive Appointments - Research Report on Celgene, Sirona, Centene, Fresenius Medical Care, and PerkinElmer
11. According to Surveyed U.S. Oncologists, Zelboraf is the Patient Share Leader in First-Line BRAF-Mutation Positive Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... , Dec. 19, 2014 Breckenridge Pharmaceutical, ... multi-product agreement with MSN Laboratories Pvt. Ltd. ( ... expect to commercialize several new ANDAs.  Under the terms ... the products exclusively to Breckenridge for the U.S. market, ... its label.  Breckenridge and MSN have agreed to develop ...
(Date:12/19/2014)... , Dec. 19, 2014 In today,s ... product,s web presence to reflect the needs of ... particular, must meet the needs of key stakeholders ... According to recent research by ... of the participating companies averaged more than $100,000 ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Building a Best-in-Class Pharma Global Brand Website 2
(Date:12/22/2014)... Super Saturday, the last Saturday before Christmas, is ... day in the 2014 holiday shopping season. , ... steady pre-Christmas stream of customers, ready to purchase marijuana ... definitely intend to take advantage…of the recreational cannabis as ... enjoying The Grass Station’s holiday sale on vape products. ...
(Date:12/22/2014)... December 22, 2014 In recognition of ... sales to Hero Reward, a local organization that provides ... , Located on a couple hundred acres ... Program offers lodging, world class fishing, hunting, hiking, horseback ... was founded several years ago to support U.S. Service ...
(Date:12/22/2014)... 7,178 small business owners and marketing professionals avoided ... opted instead to join Digital Marketer, an Austin, Texas ... annual “Black Friday Boot Camp”. , ... 5 hour online training event and raised $50,000 in ... Central Texas based charities dedicated to fighting childhood cancer. ...
(Date:12/22/2014)... 2014 NAPW honors ... of the Year. Ms. Foley is recognized with this ... most-recognized networking organization of professional women in the country, ... of Professional Women is a powerfully vibrant networking community ... , “As a nurse, I felt like I made ...
(Date:12/22/2014)... December 22, 2014 At the ... next month in San Antonio, esteemed experts ... dynamics that often stand in the way of ... , This premier faculty development opportunity is ... Leadership, whose mission is to assist nurse educators ...
Breaking Medicine News(10 mins):Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3
... May 28 In a world of internet savvy,patients ... scheduling,are readily available online. With a few clicks of ... friends and family and even buy,groceries! A patient,s experience ... be equally as user friendly., With the new ...
... mean development of new class of drugs, researchers say ... that inhibits HIV protease has been developed by researchers at ... necessary for HIV replication, is a common target in the ... HIV protease inhibitor compound to be developed in 20 years ...
... lead to more effective drugs to slow progression of ... gene that plays a role in Alzheimer,s disease in ... the neurodegenerative condition has been identified by U.S. researchers. ... 20 -- opens a new line of research that ...
... creases, saggy areas around the mouth and neck the ... are not inevitable. They result from a structural breakdown inside ... the growth of new, youthful collagen, University of Michigan scientists ... collagen collapse and possible renewal, based on more than a ...
... the University of Pennsylvania School of Medicine have shown ... decoy, receptor, binding growth factors that promote the progression ... lead to new drug designs for inhibiting cancer. The ... publication. , Many types of tumors grow because of ...
... athletes and non-athletes suffer from one or more components ... conditions that can lead to cardiovascular disease, according to ... in Milwaukee. , The study results were presented today ... by Anne Z. Hoch, D.O., associate professor of orthopedic ...
Cached Medicine News:Health News:Empowering Your Patients: Smile Dash Portal 'Bridges Gap' Between Dentists and Patients 2Health News:New Compound Slows HIV Replication 2Health News:Study IDs Gene for Late-Onset Alzheimer's 2Health News:Why some treatments rescue aging skin 2Health News:Why some treatments rescue aging skin 3Health News:Fruit fly protein acts as decoy to capture tumor growth factors, find Penn researchers 2Health News:New study shows sedentary high school girls are at significant risk for future osteoporosis 2
... Thyroid-stimulating hormone (TSH) is a 32 kDa ... the anterior pituitary gland [1]. The structure ... of the pituitary and placental gonadotropins, consisting ... identical between these hormones and a unique ...
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... primarily by 5-monodeioination of thyroxine (T4) in ... production occurs at a rate which is ... of T3 from the thyroid gland into ... to 80-100 micrograms/day for T4. In addition, ...
... Human Insulin-like growth factor binding protein-3 (IGFBP-3) is ... in postnatal serum, as a component of the ... IGFBP-3, a molecule of IGF-I or IGF-II and ... the actions of the IGFs. The molar concentration ...
Medicine Products: